Ledger.Open graph →
SEC Form D · filed December 22, 2021

Vero Biotech Inc

Offering
$99.5M
Sold
$27.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ATLANTA, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Brent V. Furse · Atlanta, GAExec · DirectorTodd Brady · Grand Forks, NDDirectorDaniel Salazar · Atlanta, GADirectorThiago V. Tavares · Atlanta, GADirectorShasha V. Zou · Atlanta, GAExecEric V. Bednarski · Atlanta, GADirectorRoberto V. Cohen · Atlanta, GAExecTodd Brady · CRANBURY, NJDirectorDaniel Salazar · Atlanta, GADirectorThiago V. Tavares · Atlanta, GADirectorShasha V. Zou · Atlanta, GAExecEric V. Bednarski · Atlanta, GADirectorBrent V. Furse · Atlanta, GAExec · DirectorRoberto V. Cohen · Atlanta, GAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗